Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Whyte

Showing results (111-120 of 165) with videos related to

Pageof 17
Sort By:
Bone|December 18, 2019
Hypophosphatemic osteosclerosis, hyperostosis, and enthesopathy associated with novel homozygous mutations of DMP1 encoding dentin matrix protein 1 and SPP1 encoding osteopontin: The first digenic SIBLING protein osteopathy?Michael P Whyte, S Deepak Amalnath, William H McAlister, et al.
American Journal of Medical Genetics. Part A|January 19, 2006
Manifestations in a family with autosomal dominant bone fragility and limb-girdle myopathySarju G Mehta, Giles D J Watts, Barbara McGillivray, et al.
American Journal of Medical Genetics. Part A|July 4, 2014
Multicentric carpotarsal osteolysis syndrome is caused by only a few domain-specific mutations in MAFB, a negative regulator of RANKL-induced osteoclastogenesisSteven Mumm, Margaret Huskey, Shenghui Duan, et al.
Bone|April 9, 2025
Transforming growth factor, beta-2 gene mutation causes autosomal dominant Camurati-Engelmann disease, type 2 (OMIM % 606631)Steven Mumm, José L Paz-Ibarra, Philippe M Campeau, et al.
Bone|April 5, 2011
Dose response of bone-targeted enzyme replacement for murine hypophosphatasiaManisha C Yadav, Isabelle Lemire, Pierre Leonard, et al.
Bone|November 26, 2016
Osteopontin and the dento-osseous pathobiology of X-linked hypophosphatemiaTchilalo Boukpessi, Betty Hoac, Benjamin R Coyac, et al.
Bone|August 7, 2025
Corrigendum to "Transforming growth factor, beta-2 gene mutation causes autosomal dominant Camurati-Engelmann disease, type 2 (OMIM % 606631)" [Bone 197 (2025) 117477]Steven Mumm, José L Paz-Ibarra, Philippe M Campeau, et al.
Bone|May 16, 2019
New explanation for autosomal dominant high bone mass: Mutation of low-density lipoprotein receptor-related protein 6Michael P Whyte, William H McAlister, Fan Zhang, et al.
European Journal of Human Genetics : EJHG|October 8, 2009
Comparison of human chromosome 19q13 and syntenic region on mouse chromosome 7 reveals absence, in man, of 11.6 Mb containing four mouse calcium-sensing receptor-related sequences: relevance to familial benign hypocalciuric hypercalcaemia type 3Fadil M Hannan, M Andrew Nesbit, Jeremy J O Turner, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 31, 2012
Enzyme replacement prevents enamel defects in hypophosphatasia miceManisha C Yadav, Rodrigo Cardoso de Oliveira, Brian L Foster, et al.
Pageof 17

Showing results (111-120 of 165) with videos related to

Sort By:
Pageof 17
Bone|December 18, 2019
Hypophosphatemic osteosclerosis, hyperostosis, and enthesopathy associated with novel homozygous mutations of DMP1 encoding dentin matrix protein 1 and SPP1 encoding osteopontin: The first digenic SIBLING protein osteopathy?Michael P Whyte, S Deepak Amalnath, William H McAlister, et al.
American Journal of Medical Genetics. Part A|January 19, 2006
Manifestations in a family with autosomal dominant bone fragility and limb-girdle myopathySarju G Mehta, Giles D J Watts, Barbara McGillivray, et al.
American Journal of Medical Genetics. Part A|July 4, 2014
Multicentric carpotarsal osteolysis syndrome is caused by only a few domain-specific mutations in MAFB, a negative regulator of RANKL-induced osteoclastogenesisSteven Mumm, Margaret Huskey, Shenghui Duan, et al.
Bone|April 9, 2025
Transforming growth factor, beta-2 gene mutation causes autosomal dominant Camurati-Engelmann disease, type 2 (OMIM % 606631)Steven Mumm, José L Paz-Ibarra, Philippe M Campeau, et al.
Bone|April 5, 2011
Dose response of bone-targeted enzyme replacement for murine hypophosphatasiaManisha C Yadav, Isabelle Lemire, Pierre Leonard, et al.
Bone|November 26, 2016
Osteopontin and the dento-osseous pathobiology of X-linked hypophosphatemiaTchilalo Boukpessi, Betty Hoac, Benjamin R Coyac, et al.
Bone|August 7, 2025
Corrigendum to "Transforming growth factor, beta-2 gene mutation causes autosomal dominant Camurati-Engelmann disease, type 2 (OMIM % 606631)" [Bone 197 (2025) 117477]Steven Mumm, José L Paz-Ibarra, Philippe M Campeau, et al.
Bone|May 16, 2019
New explanation for autosomal dominant high bone mass: Mutation of low-density lipoprotein receptor-related protein 6Michael P Whyte, William H McAlister, Fan Zhang, et al.
European Journal of Human Genetics : EJHG|October 8, 2009
Comparison of human chromosome 19q13 and syntenic region on mouse chromosome 7 reveals absence, in man, of 11.6 Mb containing four mouse calcium-sensing receptor-related sequences: relevance to familial benign hypocalciuric hypercalcaemia type 3Fadil M Hannan, M Andrew Nesbit, Jeremy J O Turner, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 31, 2012
Enzyme replacement prevents enamel defects in hypophosphatasia miceManisha C Yadav, Rodrigo Cardoso de Oliveira, Brian L Foster, et al.
Pageof 17